Skip to main content
. 2015 May 6;33(7):955–964. doi: 10.1007/s00345-015-1561-0

Table 1.

Results from focal cryotherapy studies mentioning post-treatment histological outcomes

Study Total number of patients Treatment modality Biopsy method for initial diagnosis Protocol or for-cause biopsy method Number of patients with a positive post-procedural biopsy/total number of biopsied patients Biopsy significance Subsequent treatment
Bargawi et al. [65] 62 Cryo Template mapping Protocol
12-month TRUS biopsy
12/62 (19 %)
1/12 bilateral
7/12 ipsilateral
4/12 contralateral side
7/8 NS ipsilateral
3/4 NS contra
AS (5)
Redo cryo (5)
RRP (2)
Bahn et al. [23] 73 Cryo Doppler TRUS Protocol and for cause
6- to 12-month TRUS biopsy
12/48 (25 %)
1/12–ipsilateral
11/12 contralateral side
1/1 NS ipsilateral
9/11 NS contralateral
AS (8)
Redo cryo (1)
brachy (1)
ADT (1)
Ward and Jones [3] 1149 Cryo NA For cause
TRUS biopsy
42/162 (26 %) NA NA
Truesdale et al. [24] 77 Cryo TRUS For cause
TRUS biopsy
10/22 (45 %)
2/10 ipsilateral
7/10 contralateral
1/10 bilateral
NA NA
Lambert et al. [25] 25 Cryo TRUS For cause or PSA nadir <50 %
TRUS biopsy
3/7 (43 %)
1/3 ipsilateral
2/3 contralateral
3/3 NS Redo cryo (3)
Ellis et al. [26] 60 Cryo NA Protocol
12-month TRUS biopsy
14/35 (40 %)
1/14 ipsilateral
13/14 contralateral
NA Redo cryo (12)
Lost to FU (1)
Onik et al. [27] 55 Cryo Template mapping For cause and protocol
12-month TRUS Biopsy
Protocol 0/26
For cause 4/4 in untreated portion of gland
NA Redo cryo (4)
Bahn et al. [27] 31 Cryo Doppler TRUS Protocol
6-month TRUS biopsy
1/25 (4 %)
1/1 in untreated portion of gland
NA Redo cryo (4)

Cryo cryotherapy, TRUS transrectal ultrasound-guided biopsy, NA not available, NS non-significant, ADT androgen deprivation therapy, AS active surveillance